GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Solventum Corp (NYSE:SOLV) » Definitions » Inventories, Finished Goods

SOLV (Solventum) Inventories, Finished Goods : $539 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Solventum Inventories, Finished Goods?

Solventum's quarterly finished goods increased from Jun. 2024 ($500 Mil) to Sep. 2024 ($529 Mil) and increased from Sep. 2024 ($529 Mil) to Dec. 2024 ($539 Mil).

Solventum's annual finished goods declined from Dec. 2022 ($468 Mil) to Dec. 2023 ($453 Mil) but then increased from Dec. 2023 ($453 Mil) to Dec. 2024 ($539 Mil).


Solventum Inventories, Finished Goods Historical Data

The historical data trend for Solventum's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solventum Inventories, Finished Goods Chart

Solventum Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Inventories, Finished Goods
- 408.00 468.00 453.00 539.00

Solventum Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 453.00 490.00 500.00 529.00 539.00

Solventum Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.


Solventum Business Description

Traded in Other Exchanges
Address
2510 Conway Avenue East, 3M Center, Building 275-6W, Maplewood, MN, USA, 55144
Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally.